Biovie Inc Stock Buy Hold or Sell Recommendation
| BIVI Stock | USD 3.05 0.06 1.93% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Biovie Inc is 'Strong Sell'. The recommendation algorithm takes into account all of Biovie's available fundamental, technical, and predictive indicators you will find on this site.
Check out Biovie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Biovie and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Biovie |
Execute Biovie Buy or Sell Advice
The Biovie recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Biovie Inc. Macroaxis does not own or have any residual interests in Biovie Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Biovie's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Biovie Trading Alerts and Improvement Suggestions
| Biovie Inc is way too risky over 90 days horizon | |
| Biovie Inc appears to be risky and price may revert if volatility continues | |
| Biovie Inc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (32.12 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biovie Inc currently holds about 18.64 M in cash with (27.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.62. | |
| Roughly 14.0% of the company shares are held by company insiders | |
| Latest headline from seekingalpha.com: BioVie files to sell 7.71M shares of common stock for holders |
Biovie Returns Distribution Density
The distribution of Biovie's historical returns is an attempt to chart the uncertainty of Biovie's future price movements. The chart of the probability distribution of Biovie daily returns describes the distribution of returns around its average expected value. We use Biovie Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Biovie returns is essential to provide solid investment advice for Biovie.
| Mean Return | 1.07 | Value At Risk | -9.39 | Potential Upside | 11.91 | Standard Deviation | 16.83 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Biovie historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Biovie Stock Institutional Investors
| Shares | Financial Perspectives Inc | 2024-09-30 | 59.0 | Albion Financial Group (utah) | 2024-06-30 | 50.0 | New York State Common Retirement Fund | 2024-06-30 | 35.0 | Jaffetilchin Investment Partners, Llc | 2024-09-30 | 21.0 | Sanctuary Wealth Management, Llc | 2024-09-30 | 1.0 | Spire Wealth Management | 2024-09-30 | 0.0 | Citadel Advisors Llc | 2024-06-30 | 0.0 | Millennium Management Llc | 2024-06-30 | 0.0 | Good Life Advisors, Llc | 2024-09-30 | 0.0 | Vanguard Group Inc | 2024-09-30 | 56.8 K | Envestnet Asset Management Inc | 2024-06-30 | 53.7 K |
Biovie Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (302.7K) | 4.5M | 14.1M | 819.2K | 4.4M | 2.3M | |
| Net Borrowings | (244.3K) | 1.3M | (1.4M) | 14.6M | 16.8M | 17.6M | |
| Free Cash Flow | (1.6M) | (10.5M) | (19.0M) | (40.3M) | (27.9M) | (26.5M) | |
| Other Non Cash Items | 4.8M | 124.9M | (2.1M) | 1.0B | (627.1K) | (595.8K) | |
| Net Income | (16.7M) | (130.2M) | (26.1M) | (50.3M) | (32.1M) | (33.7M) | |
| End Period Cash Flow | 37.2K | 4.5M | 18.6M | 19.5M | 23.8M | 25.0M | |
| Change To Netincome | 14.0M | 119.5M | 2.5M | 9.9M | 11.4M | 16.2M | |
| Dividends Paid | 48.7K | 17.1M | 53.6M | 886.4K | 1.0M | 968.4K |
Biovie Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Biovie or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Biovie's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Biovie stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.04 | |
β | Beta against Dow Jones | 0.11 | |
σ | Overall volatility | 16.92 | |
Ir | Information ratio | 0.06 |
Biovie Volatility Alert
Biovie Inc is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Biovie's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Biovie's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Biovie Fundamentals Vs Peers
Comparing Biovie's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biovie's direct or indirect competition across all of the common fundamentals between Biovie and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biovie or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Biovie's fundamental indicators could also be used in its relative valuation, which is a method of valuing Biovie by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Biovie to competition |
| Fundamentals | Biovie | Peer Average |
| Return On Equity | -2.08 | -0.31 |
| Return On Asset | -0.67 | -0.14 |
| Current Valuation | 37.89 M | 16.62 B |
| Shares Outstanding | 17.77 M | 571.82 M |
| Shares Owned By Insiders | 13.69 % | 10.09 % |
| Shares Owned By Institutions | 9.98 % | 39.21 % |
| Number Of Shares Shorted | 1.92 M | 4.71 M |
| Price To Earning | 18.12 X | 28.72 X |
| Price To Book | 3.85 X | 9.51 X |
| EBITDA | (31.95 M) | 3.9 B |
| Net Income | (32.12 M) | 570.98 M |
| Cash And Equivalents | 18.64 M | 2.7 B |
| Cash Per Share | 0.62 X | 5.01 X |
| Total Debt | 6.11 M | 5.32 B |
| Debt To Equity | 3.34 % | 48.70 % |
| Current Ratio | 4.50 X | 2.16 X |
| Book Value Per Share | 2.50 X | 1.93 K |
| Cash Flow From Operations | (27.95 M) | 971.22 M |
| Short Ratio | 0.15 X | 4.00 X |
| Earnings Per Share | (5.08) X | 3.12 X |
| Target Price | 5.0 | |
| Number Of Employees | 14 | 18.84 K |
| Beta | 0.9 | -0.15 |
| Market Capitalization | 54.19 M | 19.03 B |
| Total Asset | 25.21 M | 29.47 B |
| Retained Earnings | (334.23 M) | 9.33 B |
| Working Capital | 19.55 M | 1.48 B |
| Current Asset | 9 K | 9.34 B |
| Current Liabilities | 961 K | 7.9 B |
| Net Asset | 25.21 M |
Note: Acquisition by Berman Richard J of 51830 shares of Biovie subject to Rule 16b-3 [view details]
Biovie Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Biovie . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Biovie Buy or Sell Advice
When is the right time to buy or sell Biovie Inc? Buying financial instruments such as Biovie Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Biovie in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Petroleum and Natural Gas Thematic Idea Now
Petroleum and Natural Gas
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Petroleum and Natural Gas theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Petroleum and Natural Gas Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Biovie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.08) | Return On Assets (0.67) | Return On Equity (2.08) |
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.